Study Note: Massive Pulmonary Embolism (PE) – Critical Care Case

Patient Case

• Age/Sex: 55-year-old female

• Past Medical History: AIDS (CD4+ 20), dilated cardiomyopathy (LVEF 15%), prior DVT, hypertension, chronic kidney disease, multiple cerebrovascular infarcts

• Presentation: Found hypotensive and in respiratory distress at nursing home

• Initial ED Findings:

  • Temp: 100.9ºF

  • HR: 142/min

  • BP: 90/60 mmHg after fluids

  • SpO2: 99% on 100% O2 via non-rebreather

• Imaging: CT pulmonary angiogram: large bilateral pulmonary artery thrombi + segmental thrombi

• Management: Anticoagulation initiated, ICU transfer

I. Definition and Classification of Pulmonary Embolism

1. Massive PE vs Submassive PE

• Massive PE: Hemodynamic compromise

  • Criteria:

    • Systolic BP <90 mmHg or drop ≥40 mmHg for ≥15 min

    • Cardiogenic shock (hypoperfusion, hypoxia, altered consciousness, oliguria, cool extremities)

    • Circulatory collapse needing CPR

• Submassive PE: Normotensive but with right ventricular dysfunction

Rationale: Hemodynamic instability correlates with higher mortality and dictates urgency and intensity of treatment. Submassive PE may be managed with anticoagulation ± advanced therapy depending on RV dysfunction.

Key Takeaway: Shock or hypotension = massive PE.

II. Echocardiographic Findings in PE

Findings (both submassive and massive PE):

• Right ventricular (RV) dilation

• RV hypokinesis with sparing of apex (McConnell sign)

• Loss of inspiratory collapse of inferior vena cava (IVC)

• Paradoxical septal motion (interventricular septum bows to left ventricle)

• Elevated pulmonary artery systolic pressure

• Small LV area variation (low cardiac output)

• Possible patent foramen ovale

Rationale: Acute RV pressure overload occurs after >30% pulmonary vascular obstruction. Echo is essential when CT is not immediately feasible, and helps gauge RV strain and PE severity.

Key Takeaway: Echo can stratify PE severity and guide management decisions.

III. Hemodynamic Support in Massive PE

Preferred agent: Norepinephrine

• Supports BP via systemic vasoconstriction → improved coronary perfusion

• Preserves RV function

• Avoid excessive IV fluids: May worsen RV dilation → decreased coronary perfusion → vicious cycle of RV failure

Rationale: Right ventricle is preload-sensitive; fluids can exacerbate RV strain. Inotropic agents (e.g., dobutamine, amrinone) may be adjuncts if severe dysfunction persists.

Key Takeaway: Norepinephrine is first-line; fluids are used cautiously.

IV. Management When Systemic Thrombolysis Is Contraindicated

Options:

1. Surgical embolectomy: Sternotomy + manual clot removal; mortality now ~6% in experienced centers

2. Catheter-directed thrombolysis: Local thrombolytic infusion via catheter

3. Percutaneous aspiration or fragmentation thrombectomy: Includes Greenfield catheter, pigtail catheter rotation, rheolytic thrombectomy (Angiojet)

Rationale: When systemic thrombolysis is unsafe (e.g., massive hemoptysis), mechanical or catheter-based interventions can restore pulmonary flow and improve hemodynamics. Choice depends on operator experience, patient comorbidities, and clot location.

Key Takeaway: Multiple interventional options exist for high-risk patients; early consultation with IR/cardiothoracic surgery is critical.

V. IVC Filter Guidelines

ACCP Recommendations:

• Indications:

  1. PE with contraindication to anticoagulation

  2. Recurrent PE despite adequate anticoagulation

• Routine use not recommended

Rationale: IVC filters reduce immediate PE risk but do not affect long-term survival and increase DVT risk. Used selectively in high-risk patients.

Key Takeaway: Use IVC filter only when anticoagulation is unsafe or has failed.

VI. Hospital Course – Clinical Decisions

• ICU admission: Heparin drip + norepinephrine

• Persistent hypotension → norepinephrine continued; dobutamine trial limited by NSVT

• Echocardiogram: Moderate RV and RA dilation, RVSP 58 mmHg, moderate TR, dilated IVC

• Systemic thrombolysis contraindicated (massive hemoptysis)

• IR consulted → IVC filter placed; catheter thrombectomy not performed due to baseline LV dysfunction

• Outcome: Discharged on day 39, mechanical ventilation weaned, renal function improved

Decisions:

1. Heparin infusion: Standard initial anticoagulation for massive PE

2. Norepinephrine: Corrected hypotension and improved RV perfusion

3. Avoid thrombolysis: High bleeding risk → alternative interventions chosen

4. IVC filter: Prevent recurrent PE safely given anticoagulation interruption

5. Monitoring and ventilation: Supportive care essential for survival in hemodynamically unstable patients

VII. Key Clinical Takeaways

1. Massive PE = hemodynamic instability; requires ICU-level support.

2. RV dysfunction is central to PE severity; echocardiography is a critical diagnostic and prognostic tool.

3. Norepinephrine preferred over fluids or inotropes alone for hypotensive PE.

4. Alternative interventions (surgical or catheter-based) are life-saving when thrombolysis is contraindicated.

5. IVC filters are selective and reserved for high-risk cases.

6. Comprehensive care includes anticoagulation, hemodynamic support, oxygenation, and multidisciplinary consultation (IR, cardiothoracic surgery, critical care).